Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SnoreLab is a digital health company centered on a consumer mobile application that records, measures, and analyzes snoring during sleep. The product is used to help individuals track snoring severity over time, identify lifestyle or positional triggers, and monitor the effect of interventions such as nasal strips, mandibular devices, or alcohol reduction. The company appears to operate primarily as a commercial sleep-health software business rather than a therapeutics developer, with no evidence of a drug pipeline or clinical-stage biopharma assets. Its offering sits at the intersection of sleep monitoring, self-tracking, and consumer health, and may also be used as an adjunct tool for people exploring possible sleep apnea or related sleep issues.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SnoreLab.